2026 guidance assumes 2-3% volume growth in both segments
Guidance · revenue to $18.6B
UHS reported strong Q4 2025 results with 9% revenue growth and 20% adjusted EPS growth, and provided 2026 guidance for 6-8% revenue growth and 4-13% adjusted EPS growth. Management highlighted growth initiatives, AI adoption, and addressed headwinds from exchange volumes and California staffing regulations. Q4 2025 adjusted EPS was $5.88, up 20% YoY.
UHS reported strong Q4 2025 results with 9% revenue growth and 20% adjusted EPS growth, and provided 2026 guidance for 6-8% revenue growth and 4-13% adjusted EPS growth. Management highlighted growth initiatives, AI adoption, and addressed headwinds from exchange volumes and California staffing regulations. Q4 2025 adjusted EPS was $5.88, up 20% YoY.
Guidance · revenue to $18.6B
Q4 2025 adjusted EPS was $5.88, up 20% YoY.
2026 guidance implies 2-3% same-facility volume growth in both acute and behavioral segments.
Headwinds for 2026 include a $75M adverse impact from reduced ACA exchange volumes and a $35M impact from new California psychiatric staffing regulations.
Management is deploying AI across operations and administration, focusing on post-discharge care, patient safety, revenue cycle, and behavioral intake. They highlighted a partnership with Hippocratic AI and expect these efforts to drive efficiency and quality improvements, though they are early in realizing financial impact.
Las Vegas acute care volumes soft but expected to improve. Management expressed confidence in the 2026 outlook, citing strong cash generation, disciplined expense management, and specific catalysts like improvement in Las Vegas and behavioral volume growth, while acknowledging known headwinds.
Capital expenditures are expected to be $950 million to $1.1 billion in 2026, directed toward completing several large inpatient projects including a new hospital in Florida and expansions in California and Nevada, while also growing outpatient behavioral locations.
Management expressed confidence in the 2026 outlook, citing strong cash generation, disciplined expense management, and specific catalysts like improvement in Las Vegas and behavioral volume growth, while acknowledging known headwinds.
“We assume an adverse pre-tax earnings impact of approximately $75 million related to reductions in the health insurance exchanges. We assume that exchange volumes will decline by 25 to 30%”
“We expect a negative pre-tax earnings impact of approximately $35 million in our behavioral segment associated with the recently enacted California inpatient psychiatric hospital staffing regulations”
“we're using an AI agent to make those calls in many cases. And so in both cases, I think we're driving efficiencies. It allows us to reduce headcount.”
“I think probably the single biggest obstacle we've faced in not reducing length of stay further is the supply of sub-acute capacity”
| Metric | Period | Range | Midpoint | Status |
|---|---|---|---|---|
| Capex | FY2026 | $0.95B–$1.1B | $1.025B | GUIDED |
| EPS | FY2026 | $22.64–$24.52 | $23.58 | GUIDED |
| Op margin | FY2026 | $2.64B–$2.79B | $2.715B | GUIDED |
| Revenue | FY2026 | $18.4B–$18.8B | $18.6B | GUIDED |